Clinical Trials Sponsored by Heart Research U.K.

Total 1628 results

Mayo Clinic
Ottawa Heart Institute Research Corporation

Recruiting

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

Radial Artery Occlusion

United States
Ottawa Heart Institute Research Corporation
GE Healthcare

Recruiting

Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve

Coronary Artery Disease

Canada, Germany, Belgium, Japan, Singapore
Ottawa Heart Institute Research Corporation
Genome Canada

Recruiting

Predicting Development of SCAF in Device Patients

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation
GE Healthcare

Recruiting

Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF) (SPECT MBF)

Coronary Heart Disease

Canada
Ottawa Heart Institute Research Corporation
StepsCount Inc

Completed

Feasibility and Usability of a Pedometer in a Cardiovascular Disease Prevention Program for French-speaking Canadians (PiezoRx)

Cardiovascular Disease

Canada
David Birnie

Completed

The Ottawa AF Cardioversion Protocol

Atrial Fibrillation

Canada
Ottawa Heart Institute Research Corporation
GE Healthcare

Completed

123I-mIBG SPECT Imaging

Coronary Artery Disease | Heart Failure

Canada
Innovaderm Research Inc.
Abbott; Montreal Heart Institute

Completed

Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis | Coronary Atherosclerosis | Vascular Inflammation

Canada
Ottawa Heart Institute Research Corporation
Sanofi; Pfizer

Completed

A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease

Coronary Disease | Diabetes Mellitus, Type 2

Canada
Heart Center Research, LLC
Boston Scientific Corporation

Recruiting

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts (DART-HA)

Heart Failure, Congestive

United States
Pennington Biomedical Research Center
American Heart Association

Completed

WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women

Blood Pressure | Over Weight | Postmenopausal Disorder

United States
Innovaderm Research Inc.
Abbott; Montreal Heart Institute

Completed

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Psoriasis | Coronary Atherosclerosis | Vascular Inflammation

Canada
Ottawa Heart Institute Research Corporation
Edwards Lifesciences

Completed

Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement (Tissue-Valve)

Aortic Valve Disease

Canada
Beijing Anzhen Hospital
Heart Health Research Center

Recruiting

Study on the Effectiveness of AF Analysis Software in AF Rhythm Monitoring (PPG-AF)

Atrial Fibrillation | Atrial Fibrillation Paroxysmal

China
Pennington Biomedical Research Center
American Heart Association

Completed

Gaming Technology to Encourage Healthy Weight and Activity in Youth (GameSquad)

Childhood Obesity

United States
Hennepin Healthcare Research Institute
American Heart Association

Completed

Cardiovascular Prevention for Persons With HIV

HIV Infection | Cardiovascular Disease Risk

United States
COLM Study Research Organization
Japan Heart Foundation

Completed

Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

Hypertension | Cardiovascular Disease | Diabetes

Japan
U.S. Army Medical Research and Development Command

Recruiting

Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrhagic Fever With Renal Syndrome

Hantaan Virus Nephropathy | Puumala Virus Nephropathy

United States
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Recruiting

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Viral Hemorrhagic Fever

Germany
U.S. Army Medical Research and Development Command

Completed

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (MMB4(DMS))

Safety and Efficacy

United States
U.S. Army Medical Research and Development Command

Available

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Smallpox | Monkeypox
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

Malaria,Falciparum

United States
U.S. Army Medical Research and Development Command

Completed

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine (VEE TC-83)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

Eastern Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Withdrawn

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

Malaria

United States
U.S. Army Medical Research and Development Command

Withdrawn

Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany (HFRS)

Hemorrhagic Fever With Renal Syndrome

Germany
U.S. Army Medical Research and Development Command

Completed

A Double-Blind, Randomized, Placebo Controlled, Clinical Trial of an Antiplaque Chewing Gum (30 mg) - Phase 2 Proof of Concept in a Generally Healthy Patient Population (APCG)

Plaque Regrowth
U.S. Army Medical Research and Development Command

Withdrawn

Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Study of the Safety of Intravenous Artesunate

Malaria | Malaria, Cerebral

United States
U.S. Army Medical Research and Development Command

Completed

Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)

Leishmaniasis, Cutaneous

Peru
U.S. Army Medical Research and Development Command

Completed

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Completed

Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) (HOPPS)

Traumatic Brain Injury | Post-concussive Symptoms

United States
U.S. Army Medical Research and Development Command

Recruiting

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Stress Disorders, Post-Traumatic

United States
U.S. Army Medical Research and Development Command

Not yet recruiting

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults (VEE)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine

Dengue Virus

United States
U.S. Army Medical Research and Development Command

Unknown

The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome in Trauma Patients (NIRS)

Anterior Tibial Compartment Syndrome

United States
U.S. Army Medical Research and Development Command

Completed

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

Hantaan Virus

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)

Shigellosis | Bacillary Dysentery

United States
U.S. Army Medical Research and Development Command

Unknown

Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine

Western Equine Encephalitis

United States
Janssen Pharmaceutical K.K.
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64530440 in Healthy Japanese Male Participants

Healthy

Japan
U.S. Army Medical Research and Development Command

Completed

Safety Evaluation of a Q-fever Vaccine, NDBR 105

Q Fever

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
U.S. Army Medical Research and Development Command

Completed

Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults (RVEc)

Ricin Poisoning

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine (EEE)

Eastern Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Completed

Reference Values for Non-invasive Hydration Status Markers H10-14

Value Orientation

United States
U.S. Army Medical Research and Development Command

Completed

Western Equine Encephalitis Vaccine, Inactivated (WEE)

Virus

United States
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine (HOPS)

Meningococcal Infection, Group B

United States

Clinical Trials Sponsored by Heart Research U.K.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations